necitumumab

Ligand id: 8090

Name: necitumumab

References
1. Liu M, Zhu Z. (2009)
Used in treating neoplastic diseases and hyperproliferative disorders.
Patent number: US7598350. Assignee: Imclone Llc. Priority date: 19/03/2004. Publication date: 06/10/2009.
2. Sacco PC, Maione P, Rossi A, Sgambato A, Casaluce F, Palazzolo G, Gridelli C. (2015)
Necitumumab for the treatment of stage IV metastatic squamous non-small-cell lung cancer.
Expert Rev Respir Med9 (3): 245-54. [PMID:25797462]
3. Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, B├ílint B, Losonczy G et al.. (2015)
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Lancet Oncol.16 (7): 763-74. [PMID:26045340]